Search Page

1

Cite

Share

Bleeding risk and bronchoscopy: in search of the evidence in evidence-based medicine.

Chinsky K. Chinsky K. Chest. 2005 Jun;127(6):1875-7. doi: 10.1378/chest.127.6.1875. Chest. 2005. PMID: 15947291 No abstract available.

Cite

Share

2

Cite

Share

The evolving paradigm of hyperglycemia and critical illness.

Chinsky K. Chinsky K. Chest. 2004 Sep;126(3):674-6. doi: 10.1378/chest.126.3.674. Chest. 2004. PMID: 15364740 No abstract available.

Cite

Share

3

Cite

Share

Varying approaches to tracheostomy: "vive la difference".

Chinsky KD. Chinsky KD. Chest. 2005 Apr;127(4):1083-5. doi: 10.1378/chest.127.4.1083. Chest. 2005. PMID: 15821172 No abstract available.

Cite

Share

4

Cite

Share

Critical interactions : man and machine.

Chinsky KD. Chinsky KD. Chest. 2001 Apr;119(4):996-7. doi: 10.1378/chest.119.4.996. Chest. 2001. PMID: 11296158 No abstract available.

Cite

Share

5

Cite

Share

Ventilator-associated pneumonia: is there any gold in these standards?

Chinsky KD. Chinsky KD. Chest. 2002 Dec;122(6):1883-5. doi: 10.1378/chest.122.6.1883. Chest. 2002. PMID: 12475819 No abstract available.

Cite

Share

6

Cite

Share

Use of indium 111-labeled white blood cell scan in the diagnosis of cytomegalovirus pneumonia in a renal transplant recipient with a normal chest roentgenogram.

Chinsky K, Goodenberger DM. Chinsky K, et al. Chest. 1991 Mar;99(3):761-3. doi: 10.1378/chest.99.3.761. Chest. 1991. PMID: 1847325

Cite

Share

7

Cite

Share

Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial.

Andreas S, Testa M, Boyer L, Brusselle G, Janssens W, Kerwin E, Papi A, Pek B, Puente-Maestu L, Saralaya D, Watz H, Wilkinson TMA, Casula D, Di Maro G, Lattanzi M, Moraschini L, Schoonbroodt S, Tasciotti A, Arora AK, Maltais F; NTHi-Mcat-002 study group. Andreas S, et al. Lancet Respir Med. 2022 May;10(5):435-446. doi: 10.1016/S2213-2600(21)00502-6. Epub 2022 Jan 10. Lancet Respir Med. 2022. PMID: 35026180 Clinical Trial.

Cite

Share

8

Cite

Share

Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.

Maltais F, Schenkenberger I, Wielders PLML, Ortiz de Saracho J, Chinsky K, Watkins M, Millar V, Crim C. Maltais F, et al. Among authors: chinsky k. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620965145. doi: 10.1177/1753466620965145. Ther Adv Respir Dis. 2020. PMID: 33081606 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.

Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.

Cite

Share

10

Cite

Share

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators. Criner GJ, et al. N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112385 Clinical Trial.

Cite

Share